06 April 2017
Bowel Cancer Awareness Month runs throughout April.
Some of the principal treatments carried out by Dr Paul Kitchen at Spire include:
Nutrition, Liver disease, Irritable bowel syndrome, Inflammatory bowel disease, Endoscopy
I studied medicine at Oxford University, during which time I completed an MA in physiological sciences in1998. I completed my clinical training at St Georges Hospital London and qualified in 1991. Iundertook gastroenterology training at St Mark's Hospital Middlesex, Northwick Park Hospital, the Hammersmith Hospital, Chelsea and Westminster Hospital, and St Mary's Hospital London. I undertook research in Imperial College School of Medicine at the Hammersmith Campus, Cancer Research UK and St Mark's Hospital between October 1997 and May 2001. I have presented the results of this and other research nationally and internationally and was awarded his PhD in 2003 from the University of London.
I have wide experience in all aspects of gastroenterology including inflammatory bowel disease, liver disease, gastro-oesophageal reflux disease/dyspepsia and coeliac disease. I have a special interest in endoscopy. I have developed my colonoscopy practice to a high standard and was accredited as a bowel cancer screener at Medway Hospital in 2012. I have a wide experience of general (internal) medicine. I have received a number of awards for clinical excellence. I was appointed Consultant Physician and gastroenterologist in 2003 at Medway Maritime Hospital and has taken a leading role in inflammatory bowel disease, nutrition, endoscopy and bowel cancer screening.
|Private secretary||Gillian Rolfe|
|Private secretary telephone||01622 538119 / 538120|
|Private secretary fax||01634 560111|
|Private secretary firstname.lastname@example.org|
British Society of Gastroenterology.
British Medical Association.
British Association of Parenteral and Enteral Nutrition.
Royal College of Physicians
Consultant Physician and Gastroenterologist, Medway NHS Trust, Medway Maritime HospitalBack to top
09 March 2017
Ovarian cancer is often called ‘the silent killer’ but early detection can lead to successful treatment for sufferers.